Prosperity Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Prosperity Wealth Management’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,757	Closed	-$688K	–	296
2025 Q3	$688K	Buy	+1,757	New	+$734K	0.23%	99
2025 Q2	–	Sell	-1,010	Closed	-$490K	–	283
2025 Q1	$490K	Buy	+1,010	New	+$471K	0.23%	101
2024 Q4	–	Sell	-1,427	Closed	-$664K	–	251
2024 Q3	$664K	Buy	1,427 +185	+15%	+$88.9K	0.27%	66
2024 Q2	$582K	Buy	+1,242	New	+$539K	0.29%	72
2023 Q3	–	Sell	-855	Closed	-$301K	–	183
2023 Q2	$301K	Buy	855 +115	+16%	+$38.7K	0.19%	85
2023 Q1	$233K	Buy	+740	New	+$222K	0.18%	95

Other funds holding VRTX

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Prosperity Wealth Management's VRTX Position: Q4 2025 in Review

Prosperity Wealth Management sold out of Vertex Pharmaceuticals (VRTX) in Q4 2025, closing a stake of 1,757 shares — an estimated $688K sold.

Prosperity Wealth Management first reported a position in VRTX in Q1 2023 and held it in 6 quarters. The position peaked at $688K in Q3 2025. 1,668 funds tracked by Wall St. Rank hold VRTX as of Q4 2025.

Prosperity Wealth Management reported no remaining Vertex Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
Prosperity Wealth Management sold 1,757 Vertex Pharmaceuticals shares in Q4 2025, an estimated $688K.
Prosperity Wealth Management first reported a position in Vertex Pharmaceuticals in Q1 2023 and held it in 6 quarters.
Prosperity Wealth Management's Vertex Pharmaceuticals position peaked at $688K in Q3 2025.
1,668 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q4 2025.

Based on Prosperity Wealth Management's 13F filing for Q4 2025, filed 27 Mar 2026.